BI-LAMINATED ORAL DISINTEGRATING FILM FOR SYMPTOMATIC TREATMENT OF VIRAL NASOPHARYNGITIS: FORMULATION, CHARACTERIZATION, TASTE MASKING, AND STABILITY STUDIES

MERNA A. RIZK; MAHMOUD H. TEAIMA; REHAB ABDELMONEM; MOHAMED A. EL-NABARAWI; SAMMAR FATHY ELHABAL

doi:10.22159/ijap.2024v16i1.49499

Authors

MERNA A. RIZK Department of Research and Development, Eva Pharma for Pharmaceuticals and Medical Appliances, Giza-12561, Egypt https://orcid.org/0009-0004-5692-3514
MAHMOUD H. TEAIMA Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo-11562, Egypt https://orcid.org/0000-0002-7565-301X
REHAB ABDELMONEM Department of Industrial Pharmacy, College of Pharmacy, Misr University for Science and Technology (MUST), 6th of October City, Giza-12566, Egypt
MOHAMED A. EL-NABARAWI Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo-11562, Egypt
SAMMAR FATHY ELHABAL Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Modern University for Technology, and Information (MTI), Mokattam, Cairo-11571, Egypt https://orcid.org/0000-0002-7970-2288

DOI:

https://doi.org/10.22159/ijap.2024v16i1.49499

Keywords:

The oral disintegrating film, Taste masking, Ion-exchange resin, Bi-laminated, Stability studies

Abstract

Objective: Nasopharyngitis (NP) is one of the most common upper respiratory tract infections (URTIs) brought on by viral infections and requires symptomatic treatment. In this study, a new approach to delivering drugs was developed, which is a bi-laminated oral disintegrating film (ODF) containing dextromethorphan hydrobromide (DEX), phenylephrine hydrochloride (PE), and methylcobalamin (MeCbl) to support the symptomatic treatment of NP. Yet, the extreme bitterness of DEX and PE required a taste-masking technique before ODF formulation to enhance patient compliance.

Methods: Various complexing agents were tried at different ratios to mask the bitter taste of the drug(s). DEX-PE ODFs were formulated using the solvent casting procedure. A 3¹.2¹ full factorial design was performed to characterize DEX-PE ODFs, where the effects of polymer grade and plasticizer type were evaluated on the disintegration time (DT) and the percentage of drugs released after 10 min (Q₁₀).

Results: Complexation with maltodextrin (MD) and ion exchange resin (Kyron T-314) could successfully mask the bitter taste at a ratio of 1:2:2 of drugs, MD, and Kyron T-314, respectively. The ODF optimized formula (F4) recorded the least DT (5±0.5 s) and highest Q₁₀(96.7±2.1%) and (97.4±1.9%) for DEX and PE, respectively. F4 was then combined with the second film layer containing MeCbl to develop the bi-laminated ODF (B1), which was later evaluated and subjected to stability studies.

Conclusion: In conclusion, a taste-masked, bi-laminated ODF could be successfully developed for the symptomatic treatment of NP.

Downloads

Download data is not yet available.

References

Ahire YK, Bagul MB, Maru AD, Surana SS. A review of mouth dissolving film. European J Biomed Pharm Sci. 2022 Jun 11;9(7):60-5.

Shah HG, Rathod V, Basim P, Gajera B, Dave RH. Understanding the impact of multi-factorial composition on efficient loading of the stable ketoprofen nanoparticles on orodispersible films using box-behnken design. J Pharm Sci. 2022 May;111(5):1451-62. doi: 10.1016/j.xphs.2021.10.016, PMID 34678275.

Grief SN. Upper respiratory infections. Prim Care. 2013 Sep;40(3):757-70. doi: 10.1016/j.pop.2013.06.004, PMID 23958368, PMCID PMC7127764.

Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis. 2005 Nov;5(11):718-25. doi: 10.1016/S1473-3099(05)70270-X, PMID 16253889, PMCID PMC7185637.

Auda SH, El-badry M, Ibrahim MA. Design, formulation, and characterization of fast-dissolving films containing dextromethorphan. Dig J Nanomater Biostructures. 2014 Sep;9(1):133-41.

Sahu D, Sharma OP, Dhari J, Sinha AK, Sharma V, Pathak K. Kyron T-114 as an effective precursor for developing fixed-dose orodispersible formulation using taste masked resinate. Int J Drug Dev Res. 2013 Jun;5(2):393-406.

C SS. Formulation and evaluation of dextromethorphan hydrobromide controlled release hollow microspheres using natural polymer. Indonesian J Pharm 2014;25(3):181. doi: 10.14499/indonesianjpharm25iss3pp181.

Mahdi AR, Al-Bayati YK, Ameen ST. Preparation of new molecularly imprinted polymers and their use in the selective extraction for determination phenylephrine hydrochloride at pharmaceuticals. Int J Drug Deliv Technol. 2019 Dec;9(4):651-9.

Destruel PL, Zeng N, Brignole Baudouin F, Douat S, Seguin J, Olivier E. In situ gelling ophthalmic drug delivery system for the optimization of diagnostic and preoperative mydriasis: in vitro drug release, cytotoxicity and mydriasis pharmacodynamics. Pharmaceutics. 2020 Apr 15;12(4):360. doi: 10.3390/pharmaceutics12040360, PMID 32326492, PMCID PMC7238180.

Batista KS, Cintra VM, Lucena PAF, Manhaes-de-Castro R, Toscano AE, Costa LP. The role of vitamin B12 in viral infections: a comprehensive review of its relationship with the muscle-gut-brain axis and implications for SARS-CoV-2 infection. Nutr Rev. 2022 Feb 10;80(3):561-78. doi: 10.1093/nutrit/nuab092, PMID 34791425, PMCID PMC8689946.

D KJ, CJ, Singh M, K RG, Joshi H. Comparison study of vitamin-B12 for its efficacy and bioavailability of various formulations in treating pernicious anemia. Int J Pharm Pharm Sci. 2015 Oct;7(13):6-8.

Preis M, Eckert C, Hausler O, Breitkreutz J. A comparative study on solubilizing and taste-masking capacities of hydroxypropyl-β-cyclodextrin and maltodextrins with high amylose content. Sens Actuators B. 2014 Mar;193:442-50. doi: 10.1016/j.snb.2013.12.005.

Sohi H, Sultana Y, Khar RK. Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm. 2004 May;30(5):429-48. doi: 10.1081/ddc-120037477, PMID 15244079.

Suares D, Hiray A. Taste masked orodispersible formulation of fexofenadine hydrochloride using ion exchange resins. Indian J Pharm Sci. 2015 Sep-Oct;77(5):550-5. doi: 10.4103/0250-474x.169027, PMID 26798169, PMCID PMC4700707.

Sharma S, Lewis S. Taste masking technologies: a review. Int J Pharm Pharm Sci. 2010 Jan;2(2):1-3.

Kaur P, Garg R. Oral dissolving film: present and future aspects. J Drug Delivery Ther. 2018 Dec;8(6):373-7. doi: 10.22270/jddt.v8i6.2050.

Ozakar E, Sevinc Ozakar R, Yılmaz B. Preparation, characterization, and evaluation of cytotoxicity of fast dissolving hydrogel based oral thin films containing pregabalin and methylcobalamin. Gels. 2023 Feb 9;9(2):147. doi: 10.3390/gels9020147, PMID 36826317, PMCID PMC9957442.

Kawale KA, Autade NB, Narhare HS, Mhetrea RL. A review on the fast-dissolving oral film. Asian J Pharm Clin Res. 2023 Oct;16(10):7-17. doi: 10.22159/ajpcr.2023.v16i10.48099.

Teaima MH, Abdel Haleem KM, Osama M, El-Nabarawi MA, Fayez SM. Bi-laminated oral disintegrating film for dual delivery of pitavastatin calcium and lornoxicam: fabrication, characterization and pharmacokinetic study. Int J App Pharm. 2022 Mar;14(2):53-60. doi: 10.22159/ijap.2022v14i2.43534.

Gupta MS, Kumar TP, Reddy D, Pathak K, Gowda DV, Babu AVN. Development and characterization of pullulan-based orodispersible films of iron. Pharmaceutics. 2023 Mar;15(3):1027. doi: 10.3390/pharmaceutics15031027, PMID 36986887.

B KS, Chandrakala V, Srinivasan S. Formulation and evaluation of mouth-dissolving film of an H1 antihistamine drug. Int J Curr Pharm Sci. 2022 Nov;14(6):55-66.

Saab M, Mehanna MM. Disintegration time of orally dissolving films: various methodologies and in vitro/in vivo correlation. Pharmazie. 2019 Apr 1;74(4):227-30. doi: 10.1691/ph.2019.8231, PMID 30940306.

Rani KC, Parfati N, Aryani NLD, Winantari AN, Fitriani EW, Pradana AT. Development, evaluation, and molecular docking of oral dissolving film of atenolol. Pharmaceutics. 2021 Oct 19;13(10):1727. doi: 10.3390/pharmaceutics13101727, PMID 34684021, PMCID PMC8537485.

Jabbari HN, Shabani M, Monajjemzadeh F. Gliclazide compatibility with some common chemically reactive excipients: using different analytical techniques. Anal Sci Technol. 2021;34(2):46-55.

Pani NR, Nath LK, Acharya S. Compatibility studies of nateglinide with excipients in immediate release tablets. Acta Pharm. 2011 May 5;61(2):237-47. doi: 10.2478/v10007-011-0016-4, PMID 21684850.

Preis M, Woertz C, Schneider K, Kukawka J, Broscheit J, Roewer N. Design and evaluation of bilayered buccal film preparations for local administration of lidocaine hydrochloride. Eur J Pharm Biopharm. 2014 Apr;86(3):552-61. doi: 10.1016/j.ejpb.2013.12.019, PMID 24388912.

Mehmood Y, Bashir I, Yousaf H, Jamshaid U, Jamshaid M, Majeed I. Degradation study of methylcobalamin injection and change in pH by thermal stress. IOSR JPBS. 2015 May;10(3):43-8.

Zaki RM, Alfadhel M, Devanatha Desikan Seshadri V, Albagami F, Alrobaian M, Tawati SM. Fabrication and characterization of orodispersible films loaded with solid dispersion to enhance rosuvastatin calcium bioavailability. Saudi Pharm J. 2023 Jan;31(1):135-46. doi: 10.1016/j.jsps.2022.11.012, PMID 36685296, PMCID PMC9845125.

Sevinc Ozakar R, Ozakar E. Current overview of oral thin films. Turk J Pharm Sci. 2021 Feb 25;18(1):111-21. doi: 10.4274/tjps.galenos.2020.76390, PMID 33634686, PMCID PMC7957312.

Shi NQ, Jin Y, Zhang Y, Che XX, Xiao X, Cui GH. The influence of cellulosic polymer’s variables on dissolution/solubility of amorphous felodipine and crystallization inhibition from a supersaturated state. AAPS PharmSciTech. 2018 Dec 17;20(1):12. doi: 10.1208/s12249-018-1266-y, PMID 30560388.

Chaudhari SP, Dave RH. Investigating the effect of molecular weight of polyvinylpyrrolidone and hydroxypropyl methylcellulose as potential anti-precipitants on supersaturated drug solutions and formulations using the weakly acidic drug indomethacin. Int J Pharm Sci Res. 2016 Oct;7(10):3931-48.

Jadhav YG, Galgatte UC, Chaudhari PD. Overcoming poor solubility of dimenhydrinate: development, optimization and evaluation of fast dissolving oral film. Adv Pharm Bull. 2018 Nov;8(4):721-5. doi: 10.15171/apb.2018.081, PMID 30607345, PMCID PMC6311638.

Pham Le Khanh H, Nemes D, Rusznyak A, Ujhelyi Z, Feher P, Fenyvesi F. Comparative investigation of cellular effects of polyethylene glycol (PEG) derivatives. Polymers (Basel). 2022 Jan;14(2):279. doi: 10.3390/polym14020279, PMID 35054686.

Chopade S. Central composite design for the development of trimetazidine dihydrochloride-loaded fast-dissolving film. Fabad J Pharm Sci. 2023 Mar;48(1):61-74. doi: 10.55262/fabadeczacilik.1085351.